<code id='7CF217EE95'></code><style id='7CF217EE95'></style>
    • <acronym id='7CF217EE95'></acronym>
      <center id='7CF217EE95'><center id='7CF217EE95'><tfoot id='7CF217EE95'></tfoot></center><abbr id='7CF217EE95'><dir id='7CF217EE95'><tfoot id='7CF217EE95'></tfoot><noframes id='7CF217EE95'>

    • <optgroup id='7CF217EE95'><strike id='7CF217EE95'><sup id='7CF217EE95'></sup></strike><code id='7CF217EE95'></code></optgroup>
        1. <b id='7CF217EE95'><label id='7CF217EE95'><select id='7CF217EE95'><dt id='7CF217EE95'><span id='7CF217EE95'></span></dt></select></label></b><u id='7CF217EE95'></u>
          <i id='7CF217EE95'><strike id='7CF217EE95'><tt id='7CF217EE95'><pre id='7CF217EE95'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:815

          What does it mean to a bad CEO? Can biotech endure another election year? And can you go to too many J.P. Morgan parties?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s our last episode of 2023, so we look back on the biggest stories of the year, discuss the best and worst CEOs in the industry, and make some reasonably informed guesses on what 2024 has in store for the drug industry.

          advertisement

          For more on what we cover, here are the year’s best CEOs; here are the worst; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          leisure time

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          Children’s Hospital revives plan for pedestrian bridge
          Children’s Hospital revives plan for pedestrian bridge

          ArenderingoftheLongwoodAvenuefootbridgeBostonChildren’sHospitalplanstobuild.Elkus/ManfrediArchitects

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          Data integrity in scientific journals requires "effort" by publishers, institutions

          ScientificwatchdogsSholtoDavid(right)andElisabethBikjoinSTAT'sJonathenWosenattheSTATBreakthroughSumm